Replies to post #154542 on Avid Bioservices Inc (CDMO)

[EYEBUYSTOX]

Pretty telling that they didn't even mention the 2nd line NSCLC trial in the bavi trial breakdown table. Very BP-centric tone to the whole article but nice to see the mention regardless.

[biopharm]

North40000, thanks for that Jan 2014 Publication that mentions PS targeting. Slowly but surely the advancement of Bavituximab continues.

[Protector]

That's what I like about this PPHM board. There is always someone able to pull up this or that and all together we collect and find tons of information and side-information related to PPHM.

The power of the numbers I guess.

Thanks for the link.